Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
LXP Industrial Trust has pre-leased its 1.2 million square foot speculative warehouse development in Phoenix to a U.S. subsidiary of a global logistics company, with a five-year lease starting December 2026. The project, costing approximately $122 million, is expected to generate an 8.0% development cash yield, marking a significant leasing milesto…
Amgen reported first-quarter product sales up 4% and adjusted EPS rising 5% to $5.15, with revenue of $8.6 billion. Growth was supported by Repatha and rare disease medicines, even as Prolia sales fell amid patent-related competition. The company said it submitted a label amendment for Tavneos following recent FDA action and is advancing broad Phas…
Summary: Roblox said it now expects fiscal 2026 bookings of $7.33 billion to $7.6 billion, down from a prior forecast of $8.28 billion to $8.55 billion, attributing part of the change to reduced communication engagement after rolling out age-gating and broader content monitoring. The move follows rising scrutiny over child safety on the platform an…
Roku raised its annual platform revenue forecast, citing continued advertiser demand for connected TV. The company's Platform segment delivered strong quarter-over-quarter growth, and Roku increased its 2026 platform revenue target to $5 billion. Management warned that rising memory costs will pressure device margins later in the year, even as its …
Cormorant Asset Management, LP, alongside its affiliate Cormorant Global Healthcare Master Fund, LP and Bihua Chen, executed a significant sale of common stock in Bright Minds Biosciences Inc. (NASDAQ: DRUG). The transaction, which took place on April 28, 2026, involved the disposal of 109,331 shares at an average price of $89.5 per share. This liq…
Reddit forecast second-quarter revenue above analysts' averages, attributing the lift to AI-driven advertising features that enhance targeting and creative optimisation. The company also raised adjusted EBITDA guidance, reported robust first-quarter revenue growth and said active advertiser counts climbed sharply year-over-year. Reddit's hiring pla…
The Ensign Group, Inc. announced its first quarter 2026 results showing significant growth in earnings and revenue, with GAAP diluted EPS up 21.9% to $1.67 and adjusted EPS rising 21.7% to $1.85. The firm reported increased occupancy and skilled nursing revenue rates, expanded its healthcare operations portfolio with key acquisitions, and raised it…
Westwood Holdings Group, Inc. reported its Q1 2026 results showing growth in assets under management to $18.3 billion, driven by strong performance in Energy and Real Assets strategies and growth in ETFs and private energy secondaries funds. Quarterly revenues totaled $25.0 million, slightly down from the previous quarter but above last year's firs…
Resmed, a leader in health technology focused on sleep and breathing, announced the retirement of longtime CFO Brett Sandercock effective May 4, 2026. Aaron Bloomer, formerly CFO at Exact Sciences, will succeed him. The company reiterated its fiscal 2026 financial outlook, signaling stable operational expectations moving forward.
SI-BONE, Inc., a Nasdaq-listed medical device company specializing in procedural solutions for compromised bone, announced its participation in the 2026 BofA Securities Healthcare Conference with a scheduled fireside chat. The event offers management a platform to discuss company developments and engage with investors.
A recent regulatory filing with the Securities and Exchange Commission has revealed that Michelle R. Cassabaum, a director at Ames National Corp (NASDAQ: ATLO), has increased her position in the company through a purchase of common stock. The transaction, which occurred on April 30, 2026, involved the acquisition of 84 shares at a price point of $2…
Royal Caribbean (RCL) looks set to keep recovering its pricing power despite near-term oil volatility. The company trades at a reasonable P/E (~16x) with strong ROE (42.5%) and positive free cash flow. We present a mid-term trade: entry $265.00, target $320.00, stop $242.00, horizon mid term (45 trading days).
Jonathan Anderman, the General Counsel for Compass Therapeutics, Inc. (NASDAQ:CMPX), has expanded his holdings in the company through a direct purchase of common stock. The transaction, which took place on April 29, 2026, involved an acquisition of 25,000 shares via the open market at a price per share of $1.89. This move brings the total value of …
Rivian said it will receive up to $4.5 billion from the U.S. Department of Energy to build its Georgia manufacturing plant, about $2 billion less than the previously approved $6.6 billion. The company said it will draw the funds earlier than planned in 2027, expand initial annual capacity at the plant to 300,000 units from 200,000, and keep its ful…
Aligos Therapeutics, a clinical stage biotechnology company specializing in therapies for liver and viral diseases, announced it will report its first quarter 2026 financial results on May 7, 2026, after the U.S. markets close. The company focuses on developing treatments for chronic hepatitis B, metabolic-associated steatohepatitis, obesity, and c…
Cue Biopharma announces the appointment of Shao-Lee Lin, M.D., Ph.D., as CEO, President, and Board Director to steer the company’s transition into a clinical-stage biopharmaceutical company. Dr. Lin brings over 25 years of experience leading biotech firms and advancing drug candidates. The company is progressing its lead autoimmune candidate, CUE-4…
Syntec Optics Holdings, Inc. successfully closed a $20 million underwritten public offering of 2,857,142 common shares priced at $7.00 each. The company plans to use the proceeds to acquire or invest in complementary businesses, technologies, products or assets, as well as for working capital, capital expenditures, and to optimize its capital struc…
Provident Financial Services, Inc. announced a quarterly cash dividend of $0.24 per common share payable on May 29, 2026, to shareholders of record as of May 15, 2026. Provident Financial Services is the holding company for Provident Bank, serving communities in New Jersey, Pennsylvania, and New York with banking, wealth management, and insurance s…
Cibus, Inc., an agricultural technology company specializing in gene editing plant traits, will report its first quarter 2026 financial results on May 14, 2026, followed by a conference call. The company focuses on developing traits to improve crop productivity, yield, and sustainability, licensing these traits to seed companies.
PEDEVCO Corp. (NYSE American: PED), an energy company specializing in strategic oil and gas assets mainly in the Rocky Mountain and Permian Basins, announced its first quarter 2026 financial results will be released prior to a conference call on May 14, 2026. The company recently completed a merger in October 2025, significantly expanding its asset…
Matrix Service Company, a leading engineering and construction firm for energy and industrial markets, announced that CFO Kevin Cavanah will leave the company after the filing of the fiscal 2026 Annual Report. The company has engaged an executive search firm to find a replacement. The departure is not due to disagreements on accounting or operation…
Trupanion, Inc., a leading pet medical insurance provider, reported its first quarter 2026 results showing 12% total revenue growth year-over-year to $384 million, driven largely by a 16% increase in subscription revenue. The company achieved net income of $4.9 million, a significant improvement from a net loss in Q1 2025, supported by strong adjus…
Larimar Therapeutics announced the publication of research demonstrating that treatment with their lead drug candidate, nomlabofusp, increases frataxin (FXN) levels in tissues relevant to Friedreich’s Ataxia (FA). These frataxin increases correlate between critical tissues and accessible peripheral tissues such as skin and buccal cells, supporting …
Swarmer, Inc, a Nasdaq-listed drone autonomy software company, announced its Q1 2026 earnings release and conference call scheduled for May 13, 2026. The company supports drone operations in Ukraine and has completed over 100,000 combat missions. Swarmer provides autonomous swarm coordination and AI-powered control software primarily licensed to dr…
Resmed Inc. announced its Q3 fiscal 2026 results with revenue up 11% to $1.43 billion and non-GAAP diluted EPS increasing 21% to $2.86. The company achieved 290 basis points gross margin improvement and 18% increase in non-GAAP operating income. Growth was driven by higher sales of sleep devices, masks, and software, with expansion in U.S., Canada,…
